Regulation of extrarenal synthesis of 1,25-dihydroxyvitamin D3 - Relevance for colonic cancer prevention and therapy

Molecular Aspects of Medicine

Volumn 24, Issue 6, 2003, Pages 459-465

  Cross, Heide S ^a   Kállay, Enikö ^a   Khorchide, Maya ^a   Lechner, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

1,25 dihydroxyvitamin D3 synthesis and degradation; Colonic tumor prevention; CYP24; CYP27B1; Estrogen receptors and

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24; CYTOCHROME P450 27B1; ESTROGEN; OXYGENASE; PHYTOESTROGEN; SOYBEAN PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

CELL DIFFERENTIATION; CELL LINE; CELL STRAIN CACO 2; COLON CARCINOMA; CYPRINIFORMES; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FOOD COMPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SUNLIGHT; TUMOR GROWTH; UPREGULATION;

EID: 0142216379     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(03)00041-4     Document Type: Review

References (20)

1. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., Gray J.W., Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25:2000;144-146.
2. Bareis P., Bises G., Bischof M.G., Cross H.S., Peterlik M. 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 285:2001;1012-1017.
3. Campbell-Thompson M., Lynch I.J., Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res. 61(2):2001;632-640.
4. Cross H.S., Pavelka M., Slavik J., Peterlik M. Growth control of human colon cancer cells by vitamin D and calcium in vitro. J. Nat. Cancer Inst. 84:1992;1355-1357.
5. Cross H.S., Peterlik M., Reddy G.S., Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1α-hydroxylase activity and regulation of side chain metabolism. J. Steroid Biochem. Mol. Biol. 62:1997;21-28.
6. Cross H.S., Bareis P., Hofer H., Bischof M.G., Bajna E., Kriwanek S., Bonner E., Peterlik M. 25-hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids. 66:2001;287-292.
7. Fiorelli G., Picariello L., Martineti V., Tonelli F., Brandi M.L. Functional estrogen receptor beta in colon cancer cells. Biochem. Biophys. Res. Commun. 261:1999;521-527.
8. Foley E.F., Jazaeri A.A., Shupnik M.A., Jazaeri O., Rice L.W. Selective loss of estrogen receptor β in malignant human colon. Cancer Res. 60:2000;245-248.
9. Garland C.F., Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9:1980;227-231.
10. Gershbein L.L. Action of estrogen and adrenocorticoids on adenocarcinoma induction by 1,2-dimethylhydrazine in male rats. Res. Commun. Chem. Pathol. Pharmacol. 81:1993;117-120.
11. Grant W.B. An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer. 94:2002;1867-1875.
12. Hofer H., Ho G.-M., Peterlik M., Uskokovic M.R., Lee J.K., White M.C., Posner, Cross H.S. Biological effects of 1α-hydroxy- and 1β-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J. Pharmacol. Exp. Therapeutics. 291:1999;450-455.
13. Kállay E., Pietschmann P., Toyokuni S., Bajna E., Hahn P., Mazzucco K., Bieglmayer C., Kato S., Cross H.S. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis. 22:2001;1429-1435.
14. Leygue E., Dotzlaw H., Watson P., Murphy L.C. Altered estrogen receptor α and β messenger RNA expression during human breast cancer tumorigenesis. Cancer Res. 58:1998;3197-3201.
15. Ochiai M., Watanabe M., Kushida H., Wakabayashi K., Sugimura T., Nagao M. DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis. 17:1996;95-98.
16. Potter J.D., Bostick R.M., Grandits G.A., Fosdick L., Elmer P., Wood J., Grambsch P., Louis T.A. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev. 10:1996;779-784.
17. Sathyamoorthy N., Wang T.T. Differential effects of dietary phytoestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer. 33:1997;2384-2389.
18. Sheinin Y., Kaserer K., Wrba F., Wenzl E., Kriwanek S., Peterlik M., Cross H.S. In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch. 437:2000;501-507.
19. Smirnoff P., Liel Y., Gnainsky J., Shany S., Schwartz B. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol. Res. 11:1999;255-264.
20. Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 288:2002;321-333.